Lilly has been under pressure in the US over its pricing for insulin products, and earlier this year launched a generic of its own Humalog brand of fast-acting insulin in an attempt to fend off ...

Novo Nordisk (NYSE: NVO) shareholders know all about the ups and downs of pharmaceutical stock investing. From the beginning ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Up until a few years ago, Novo Nordisk was mainly known for selling insulin ... under the brand name Wegovy. By then, though, physicians had already begun prescribing Ozempic off-label as a ...

The initiatives to improve healthcare access — including Ayushman Bharat, which provides financial protection and better ...

Most of these medications are primarily used for type 2 diabetes, but they can also be prescribed off-label to support ... companies Novo Nordisk and Eli Lilly. These drug manufacturers also ...

Semaglutide — the active ingredient in the brand-name meds Ozempic ... GLP-1 plays a key role in stimulating insulin production and regulating blood sugar levels (glucose).

Semaglutide, which is sold under patent by innovator Novo Nordisk, is going off patent in ... Innovator Eli Lilly, whose weight loss drug Tirzepatide is sold under brand name Mounjaro, is also ...